WFMPM
DGX icon

Woodley Farra Manion Portfolio Management’s Quest Diagnostics DGX Stock Holding History

Woodley Farra Manion Portfolio Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-200
Closed -$23K – 158
2020
Q2 		$23K Hold
200
– – ﹤0.01% 219
2020
Q1 		$16K Hold
200
– – ﹤0.01% 248
2019
Q4 		$21K Buy
+200
New +$20.9K ﹤0.01% 236

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Woodley Farra Manion Portfolio Management's DGX Position: Q3 2020 in Review

Woodley Farra Manion Portfolio Management sold out of Quest Diagnostics (DGX) in Q3 2020, closing a stake of 200 shares — an estimated $23K sold.

Woodley Farra Manion Portfolio Management first reported a position in DGX in Q4 2019 and held it in 3 quarters. The position peaked at $23K in Q2 2020. 758 funds tracked by Wall St. Rank hold DGX as of Q3 2020.

  • Woodley Farra Manion Portfolio Management reported no remaining Quest Diagnostics position as of Q3 2020 after selling out during the quarter.
  • Woodley Farra Manion Portfolio Management sold 200 Quest Diagnostics shares in Q3 2020, an estimated $23K.
  • Woodley Farra Manion Portfolio Management first reported a position in Quest Diagnostics in Q4 2019 and held it in 3 quarters.
  • Woodley Farra Manion Portfolio Management's Quest Diagnostics position peaked at $23K in Q2 2020.
  • 758 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2020.

Based on Woodley Farra Manion Portfolio Management's 13F filing for Q3 2020, filed 5 Nov 2020.